| 000 | 01870 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518090956.0 | ||
| 264 | 0 | _c20210111 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1533-4023 | ||
| 024 | 7 |
_a10.1097/FJC.0000000000000815 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGao, Xiaojian | |
| 245 | 0 | 0 |
_aUrsolic Acid Improves Monocrotaline-Induced Right Ventricular Remodeling by Regulating Metabolism. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _c06 2020 |
||
| 300 |
_a545-555 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCarnitine O-Palmitoyltransferase _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
| 650 | 0 | 4 |
_aFatty Acids _xmetabolism |
| 650 | 0 | 4 | _aFibrosis |
| 650 | 0 | 4 |
_aHeart Ventricles _xdrug effects |
| 650 | 0 | 4 |
_aHypertrophy, Right Ventricular _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMonocrotaline |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aPPAR alpha _xmetabolism |
| 650 | 0 | 4 |
_aPulmonary Arterial Hypertension _xchemically induced |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aTriterpenes _xpharmacology |
| 650 | 0 | 4 |
_aVentricular Function, Right _xdrug effects |
| 650 | 0 | 4 |
_aVentricular Remodeling _xdrug effects |
| 650 | 0 | 4 | _aUrsolic Acid |
| 700 | 1 | _aZhang, Zeyu | |
| 700 | 1 | _aLi, Xin | |
| 700 | 1 | _aWei, Qingxia | |
| 700 | 1 | _aLi, Hanlu | |
| 700 | 1 | _aLi, Chen | |
| 700 | 1 | _aChen, Haixu | |
| 700 | 1 | _aLiu, Chunlei | |
| 700 | 1 | _aHe, Kunlun | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 75 _gno. 6 _gp. 545-555 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FJC.0000000000000815 _zAvailable from publisher's website |
| 999 |
_c30712624 _d30712624 |
||